Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.8 | 0.6 | 0.2 |
| Revenue growth | 34.1% | 274.3% | |
| Cost of goods sold | 18.4 | 7.8 | 5.7 |
| Gross profit | -17.6 | -7.2 | -5.5 |
| Gross margin | -2310.2% | -1265.6% | -3641.4% |
| Selling, general and administrative | 13.6 | 13.3 | 5.1 |
| Research and development | 9.5 | 8.8 | 6.6 |
| General and administrative | | | 0.0 |
| EBIT | -42.4 | -29.5 | -17.3 |
| EBIT margin | -5560.8% | -5179.1% | -11369.1% |
| Pre-tax income | -144.6 | -137.3 | -18.3 |
| Income taxes | 0.1 | 0.0 | 0.0 |
| Net income | -158.5 | -170.4 | -98.8 |
| Net margin | -20772.9% | -29948.7% | -64980.3% |
| |
| Diluted EPS | ($6.73) | ($23.20) | ($6.27) |
| Shares outstanding (diluted) | 23.6 | 7.3 | 15.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|